These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32151632)

  • 1. A cross-sectional report on melasma among Hispanic patients: Evaluating the role of oral tranexamic acid versus oral tranexamic acid plus hydroquinone.
    Arreola Jauregui IE; Huerta Rivera G; Soria Orozco M; Meyer-Nava S; Paniagua Santos JE; López Zaldo JB; Meyer-Nava I; Madrid Carrillo C; Zaldo Rolón IE; Baeza Echeverría AE; Vázquez Huerta M
    J Am Acad Dermatol; 2020 Nov; 83(5):1457-1458. PubMed ID: 32151632
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
    Basit A; Rahman A; Uddin R
    J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral tranexamic acid for the treatment of melasma.
    Ali FR
    Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
    Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
    Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of melasma using tranexamic acid: what's known and what's next.
    Sheu SL
    Cutis; 2018 Feb; 101(2):E7-E8. PubMed ID: 29554171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study.
    Chowdhary B; Mahajan VK; Mehta KS; Chauhan PS; Sharma V; Sharma A; Vashist S; Kumar P
    Arch Dermatol Res; 2021 Mar; 313(2):109-117. PubMed ID: 32356007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4% hydroquinone versus 4% hydroquinone, 0.05% dexamethasone and 0.05% tretinoin in the treatment of melasma: a comparative study.
    Astaneh R; Farboud E; Nazemi MJ
    Int J Dermatol; 2005 Jul; 44(7):599-601. PubMed ID: 15985034
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of melasma with oral administration of compound tranexamic acid: a preliminary clinical trial.
    Li Y; Sun Q; He Z; Fu L; He C; Yan Y
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):393-4. PubMed ID: 23848176
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
    Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
    Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
    Zhu CY; Li Y; Sun QN; Takada A; Kawada A
    Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
    Malik F; Hanif MM; Mustafa G
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal azelaic acid 20% cream vs hydroquinone 4% cream as adjuvant to oral tranexamic acid in melasma: a comparative study.
    Akl EM
    J Dermatolog Treat; 2022 Jun; 33(4):2008-2013. PubMed ID: 33823725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
    Saki N; Darayesh M; Heiran A
    J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.